Harvard Bioscience Inc (NASDAQ:HBIO)

3.26
Delayed Data
As of Aug 12
 -0.03 / -0.91%
Today’s Change
3.23
Today|||52-Week Range
8.75
-53.76%
Year-to-Date
Bruker (BRKR) Meets Q2 Earnings Estimates
Aug 03 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close3.29
Today’s open3.29
Day’s range3.24 - 3.29
Volume2,017
Average volume (3 months)261,357
Market cap$136.6M
Data as of 3:59pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)+96.49%
Earnings growth (this year)-12.00%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+16.46%
P/E ratioNM
Price/Sales2.39
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
--Standard BioTools In...+0.02+1.15%
LABStandard BioTools In...+0.03+1.72%
BFNHBioForce Nanoscience...0.000.00%
--Chromocure Inc0.000.00%
Data as of 3:59pm ET, 08/12/2022

Financials

Next reporting dateOctober 27, 2022
EPS forecast (this quarter)$0.07
Annual revenue (last year)$118.9M
Annual profit (last year)-$288.0K
Net profit margin-0.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Holliston, Massachusetts

Forecasts